Considering that IBD could manifest as ulcerative colitis and Crohn’s disease, several authors have evaluated the effectiveness of fecal lactoferrin in differentiating the two conditions, showing that it is more effective in diagnosing and assessing ulcerative colitis rather than Crohn’s disease activity [181,182,183]. The gene discussed is LTF; the disease is inflammatory bowel disease.